A transgenic rat with the human ATTR V30M: a novel tool for analyses of ATTR metabolisms.
A transgenic rat with the human ATTR V30M: a novel tool for analyses of ATTR metabolisms.
复制标题
DOI:
10.1016/j.bbrc.2006.11.045
复制
发表时间:
2007-01
影响因子:
3.1
通讯作者:
M. Ueda;Y. Ando;Y. Hakamata;Masaaki Nakamura;T. Yamashita;K. Obayashi;S. Himeno;Seiichiro Inoue;Yuki Sato;Takashi Kaneko;N. Takamune;S. Misumi;S. Shoji;M. Uchino;E. Kobayashi
中科院分区:
文献类型:
--
作者:
M. Ueda;Y. Ando;Y. Hakamata;Masaaki Nakamura;T. Yamashita;K. Obayashi;S. Himeno;Seiichiro Inoue;Yuki Sato;Takashi Kaneko;N. Takamune;S. Misumi;S. Shoji;M. Uchino;E. Kobayashi
Amyloidogenic transthyretin (ATTR) is the pathogenic protein of familial amyloidotic polyneuropathy (FAP). To establish a tool for analyses of ATTR metabolisms including after liver transplantations, we developed a transgenic rat model expressing human ATTR V30M and confirmed expressions of human ATTR V30M in various tissues. Mass spectrometry for purified TTR revealed that rat intrinsic TTR and human ATTR V30M formed tetramers. Congo red staining and immunohistochemistry revealed that nonfibrillar deposits of human ATTR V30M, but not amyloid deposits, were detected in the gastrointestinal tracts of the transgenic rats. At 24h after liver transplantation, serum human ATTR V30M levels in transgenic rats that received livers from normal rats became lower than detectable levels. These results thus suggest that this transgenic rat may be a useful animal model which analyzes the metabolism of human ATTR V30M including liver transplantation studies.